Dermatological device developer Kleresca said today that it has been certified by the Medical Device Single Audit Program (MDSAP), boosting its plan to enter new markets. The audit gave Kleresca regulatory clearance to enter the medical device markets of Australia and Canada. With minor additional audits and approvals, the certification will also apply to Brazil, Japan, and the United States, […]
kleresca
Kleresca wins CE Mark for biophotonic dermatological system
Dermatological device developer Kleresca said yesterday it won CE Mark approval in the European Union for its biophotonic dermatological technology platform. The Kleresca biophotonic system uses fluorescent light energy to stimulate biological processes and repair mechanisms in the skin, the company said. Kleresca said that hte clearance will allow it to “consolidate its business on […]
